Publication | Open Access

Cladribine and low-dose cytarabine alternating with decitabine as front-line therapy for elderly patients with acute myeloid leukaemia: a phase 2 single-arm trial

Hematological MalignancyElderly PatientsSingle-arm TrialMedicineMixed-phenotype Acute LeukemiaHematologyClinical TrialsMyeloid NeoplasiaLow-dose CytarabinePharmacotherapyOncologyRadiation OncologyHealth Sciences